GSK3beta: a master switch and a promising target
Glycogen synthase kinase 3 beta (GSK3beta) is a multifunctional serine/threonine kinase, which plays a major role in various signaling pathways. More than two decades after its discovery, various pharmaceutical companies are focusing on this protein as a target of interest for various therapeutic co...
Gespeichert in:
| Veröffentlicht in: | Expert opinion on therapeutic targets 2008-11, Vol.12 (11), p.1443-1455 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1455 |
|---|---|
| container_issue | 11 |
| container_start_page | 1443 |
| container_title | Expert opinion on therapeutic targets |
| container_volume | 12 |
| creator | Kannoji, Akanksha Phukan, Samiron Sudher Babu, V Balaji, Vitukudi N |
| description | Glycogen synthase kinase 3 beta (GSK3beta) is a multifunctional serine/threonine kinase, which plays a major role in various signaling pathways. More than two decades after its discovery, various pharmaceutical companies are focusing on this protein as a target of interest for various therapeutic conditions.
To discuss the major developments in the area of GSK3beta as a therapeutic target globally and its role in disease physiology and give an overview of the classes of compounds designed for its inhibition.
Data generated by various workers has helped the pharmaceutical players to put GSK3beta in their portfolio. Since it is involved in various pathways of disease physiologies, understanding of the full spectrum of the role of GSK3beta in relation to its structure and function is necessary to put successful modulators into clinical use. |
| doi_str_mv | 10.1517/14728222.12.11.1443 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69660777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69660777</sourcerecordid><originalsourceid>FETCH-LOGICAL-p549-66b44d8a36a62ba3257a22bbf6269f9e95fdd623c2ecd150d85d2ccf8143cd813</originalsourceid><addsrcrecordid>eNo1T11LwzAUDYK4Of0FgvTJt87cm-Qm8U2Gm-LAB_de0iSdlXarTYv47y044cCBw-F8MHYDfAkK9D1IjQYRlzABliClOGNz0FLmmgTM2GVKn5wjt4ou2AyMUUDWzhnfvL-KMg7uIXNZ69IQ-yx914P_yNwhTFrXH9s61Yd9Nrh-H4crdl65JsXrEy_Ybv20Wz3n27fNy-pxm3dK2pyolDIYJ8gRlk6g0g6xLCtCspWNVlUhEAqP0QdQPBgV0PvKgBQ-GBALdvcXO_V_jTENxbTCx6Zxh3gcU0GWiGutJ-PtyTiWbQxF19et63-K_4viF5PeUCU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69660777</pqid></control><display><type>article</type><title>GSK3beta: a master switch and a promising target</title><source>MEDLINE</source><source>Taylor & Francis</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Kannoji, Akanksha ; Phukan, Samiron ; Sudher Babu, V ; Balaji, Vitukudi N</creator><creatorcontrib>Kannoji, Akanksha ; Phukan, Samiron ; Sudher Babu, V ; Balaji, Vitukudi N</creatorcontrib><description>Glycogen synthase kinase 3 beta (GSK3beta) is a multifunctional serine/threonine kinase, which plays a major role in various signaling pathways. More than two decades after its discovery, various pharmaceutical companies are focusing on this protein as a target of interest for various therapeutic conditions.
To discuss the major developments in the area of GSK3beta as a therapeutic target globally and its role in disease physiology and give an overview of the classes of compounds designed for its inhibition.
Data generated by various workers has helped the pharmaceutical players to put GSK3beta in their portfolio. Since it is involved in various pathways of disease physiologies, understanding of the full spectrum of the role of GSK3beta in relation to its structure and function is necessary to put successful modulators into clinical use.</description><identifier>EISSN: 1744-7631</identifier><identifier>DOI: 10.1517/14728222.12.11.1443</identifier><identifier>PMID: 18851699</identifier><language>eng</language><publisher>England</publisher><subject>Amino Acid Sequence ; Glycogen Synthase Kinase 3 - antagonists & inhibitors ; Glycogen Synthase Kinase 3 - chemistry ; Glycogen Synthase Kinase 3 - metabolism ; Glycogen Synthase Kinase 3 beta ; Humans ; Molecular Sequence Data</subject><ispartof>Expert opinion on therapeutic targets, 2008-11, Vol.12 (11), p.1443-1455</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18851699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kannoji, Akanksha</creatorcontrib><creatorcontrib>Phukan, Samiron</creatorcontrib><creatorcontrib>Sudher Babu, V</creatorcontrib><creatorcontrib>Balaji, Vitukudi N</creatorcontrib><title>GSK3beta: a master switch and a promising target</title><title>Expert opinion on therapeutic targets</title><addtitle>Expert Opin Ther Targets</addtitle><description>Glycogen synthase kinase 3 beta (GSK3beta) is a multifunctional serine/threonine kinase, which plays a major role in various signaling pathways. More than two decades after its discovery, various pharmaceutical companies are focusing on this protein as a target of interest for various therapeutic conditions.
To discuss the major developments in the area of GSK3beta as a therapeutic target globally and its role in disease physiology and give an overview of the classes of compounds designed for its inhibition.
Data generated by various workers has helped the pharmaceutical players to put GSK3beta in their portfolio. Since it is involved in various pathways of disease physiologies, understanding of the full spectrum of the role of GSK3beta in relation to its structure and function is necessary to put successful modulators into clinical use.</description><subject>Amino Acid Sequence</subject><subject>Glycogen Synthase Kinase 3 - antagonists & inhibitors</subject><subject>Glycogen Synthase Kinase 3 - chemistry</subject><subject>Glycogen Synthase Kinase 3 - metabolism</subject><subject>Glycogen Synthase Kinase 3 beta</subject><subject>Humans</subject><subject>Molecular Sequence Data</subject><issn>1744-7631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1T11LwzAUDYK4Of0FgvTJt87cm-Qm8U2Gm-LAB_de0iSdlXarTYv47y044cCBw-F8MHYDfAkK9D1IjQYRlzABliClOGNz0FLmmgTM2GVKn5wjt4ou2AyMUUDWzhnfvL-KMg7uIXNZ69IQ-yx914P_yNwhTFrXH9s61Yd9Nrh-H4crdl65JsXrEy_Ybv20Wz3n27fNy-pxm3dK2pyolDIYJ8gRlk6g0g6xLCtCspWNVlUhEAqP0QdQPBgV0PvKgBQ-GBALdvcXO_V_jTENxbTCx6Zxh3gcU0GWiGutJ-PtyTiWbQxF19et63-K_4viF5PeUCU</recordid><startdate>200811</startdate><enddate>200811</enddate><creator>Kannoji, Akanksha</creator><creator>Phukan, Samiron</creator><creator>Sudher Babu, V</creator><creator>Balaji, Vitukudi N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200811</creationdate><title>GSK3beta: a master switch and a promising target</title><author>Kannoji, Akanksha ; Phukan, Samiron ; Sudher Babu, V ; Balaji, Vitukudi N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p549-66b44d8a36a62ba3257a22bbf6269f9e95fdd623c2ecd150d85d2ccf8143cd813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Amino Acid Sequence</topic><topic>Glycogen Synthase Kinase 3 - antagonists & inhibitors</topic><topic>Glycogen Synthase Kinase 3 - chemistry</topic><topic>Glycogen Synthase Kinase 3 - metabolism</topic><topic>Glycogen Synthase Kinase 3 beta</topic><topic>Humans</topic><topic>Molecular Sequence Data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kannoji, Akanksha</creatorcontrib><creatorcontrib>Phukan, Samiron</creatorcontrib><creatorcontrib>Sudher Babu, V</creatorcontrib><creatorcontrib>Balaji, Vitukudi N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Expert opinion on therapeutic targets</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kannoji, Akanksha</au><au>Phukan, Samiron</au><au>Sudher Babu, V</au><au>Balaji, Vitukudi N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GSK3beta: a master switch and a promising target</atitle><jtitle>Expert opinion on therapeutic targets</jtitle><addtitle>Expert Opin Ther Targets</addtitle><date>2008-11</date><risdate>2008</risdate><volume>12</volume><issue>11</issue><spage>1443</spage><epage>1455</epage><pages>1443-1455</pages><eissn>1744-7631</eissn><abstract>Glycogen synthase kinase 3 beta (GSK3beta) is a multifunctional serine/threonine kinase, which plays a major role in various signaling pathways. More than two decades after its discovery, various pharmaceutical companies are focusing on this protein as a target of interest for various therapeutic conditions.
To discuss the major developments in the area of GSK3beta as a therapeutic target globally and its role in disease physiology and give an overview of the classes of compounds designed for its inhibition.
Data generated by various workers has helped the pharmaceutical players to put GSK3beta in their portfolio. Since it is involved in various pathways of disease physiologies, understanding of the full spectrum of the role of GSK3beta in relation to its structure and function is necessary to put successful modulators into clinical use.</abstract><cop>England</cop><pmid>18851699</pmid><doi>10.1517/14728222.12.11.1443</doi><tpages>13</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1744-7631 |
| ispartof | Expert opinion on therapeutic targets, 2008-11, Vol.12 (11), p.1443-1455 |
| issn | 1744-7631 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69660777 |
| source | MEDLINE; Taylor & Francis; Taylor & Francis Medical Library - CRKN |
| subjects | Amino Acid Sequence Glycogen Synthase Kinase 3 - antagonists & inhibitors Glycogen Synthase Kinase 3 - chemistry Glycogen Synthase Kinase 3 - metabolism Glycogen Synthase Kinase 3 beta Humans Molecular Sequence Data |
| title | GSK3beta: a master switch and a promising target |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A13%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GSK3beta:%20a%20master%20switch%20and%20a%20promising%20target&rft.jtitle=Expert%20opinion%20on%20therapeutic%20targets&rft.au=Kannoji,%20Akanksha&rft.date=2008-11&rft.volume=12&rft.issue=11&rft.spage=1443&rft.epage=1455&rft.pages=1443-1455&rft.eissn=1744-7631&rft_id=info:doi/10.1517/14728222.12.11.1443&rft_dat=%3Cproquest_pubme%3E69660777%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69660777&rft_id=info:pmid/18851699&rfr_iscdi=true |